High-Protein Diet, CKD, and a Potassium Salt Substitute
Mr. A is a 58-year-old man with type 2 diabetes for 14 years and CKD stage 3b (eGFR 38 mL/min/1.73 m², stable over 8 months). HbA1c is 8.9%, blood pressure is 138/82 mmHg on ramipril, and he takes metformin 1,000 mg twice daily. He weighs 96 kg, is 1.75 m tall, and reports following a high-protein diet from a fitness app: 1.5 g/kg/day protein, mostly from red meat and whey shakes, plus a potassium-based salt substitute because 'it's healthier than salt.' Labs: potassium 5.2 mmol/L, bicarbonate 21 mmol/L, phosphate 1.5 mmol/L, albumin 3.9 g/dL. He has no edema and reports no hypoglycemia. He asks whether he should stop metformin, whether his protein intake is damaging his kidneys, and whether he can keep the salt substitute. His nephrologist has asked you to comment on targets and monitoring.
1. Evaluate his protein intake and prescribe a defensible target. Show your calculations and the rationale.
Read the worked answer
His current protein intake is about 1.5 g/kg actual body weight, or roughly 144 g/day on 96 kg-well above the 0.8 g/kg/day recommended for CKD stage 3b without dialysis. Use an adjusted body weight because of obesity: ideal body weight is about 70 kg, adjusted about 76 kg, so the target is about 60–65 g/day. That is a substantial change; reduce gradually to maintain adherence.
Counsel on distribution (20–25 g per meal), choose plant proteins and fish more often, and stop the whey shakes, which are a concentrated source with little nutritional context. High protein does not reverse CKD and may increase hyperfiltration and potassium/phosphorus load. He should not go to 0.6 g/kg either-that is for selected patients with close monitoring, not self-prescribed. Recheck albumin, phosphate, and potassium in 4–6 weeks.
2. What is your advice on glycemic targets and metformin at this eGFR?
Read the worked answer
An HbA1c of 8.9% is above his individualized target; for CKD stage 3b with no severe hypoglycemia, 7.0–8.0% is reasonable. Metformin at eGFR 38 can be continued with dose reduction-FDA guidance is to cap at 1,000 mg/day when eGFR is 30–45 and stop if eGFR falls below 30 or with acute illness. So 'stop metformin' is not automatic; reduce to 500 mg twice daily and monitor renal function.
Consider adding an SGLT2 inhibitor for kidney and cardiovascular protection if not contraindicated, and review agents with hypoglycemia risk. Monitor vitamin B12 annually on metformin. Do not intensify without addressing diet, and coordinate with the nephrologist. Explain that improving glycemia and blood pressure together slows progression more than any single supplement.
3. Address the potassium salt substitute and set a monitoring plan for the next month.
Read the worked answer
Stop the potassium-based salt substitute immediately. With eGFR 38 and ramipril, potassium 5.2 mmol/L plus a daily potassium chloride substitute is a predictable risk of hyperkalemia. Substitute herbs, pepper, lemon, and vinegar for salt. Repeat potassium and bicarbonate within one week; if K ≥5.5 or ECG changes appear, arrange urgent review. Bicarbonate 21 is borderline; monitor and discuss alkali therapy with nephrology. Phosphate 1.5 is at the upper limit; review dietary sources and repeat.
Provide a potassium food list and a medication review-avoid NSAIDs and check for other hidden potassium sources. Reassess weight, blood pressure, and a 3-day food record at 4 weeks. Document the salt-substitute counseling clearly, because it is the most immediately dangerous item on his list.